Search Results - "Andrew Livingston, J."

Refine Results
  1. 1
  2. 2

    Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association by Wu, Chia-Chin, Wang, Y. Alan, Livingston, J. Andrew, Zhang, Jianhua, Futreal, P. Andrew

    Published in Nature communications (10-01-2022)
    “…Owing to a lack of response to the anti-PD1 therapy for most cancer patients, we develop a network approach to infer genes, pathways, and potential therapeutic…”
    Get full text
    Journal Article
  3. 3

    Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer by Mull, Benjamin B., Livingston, J. Andrew, Patel, Nalini, Bui, Tuyen, Hunt, Kelly K., Keyomarsi, Khandan

    Published in British journal of cancer (17-03-2020)
    “…Background Low-dose UCN-01 mediates G1 arrest in normal proliferating cell lines with an intact G1 to S transition but not tumour cells with a deregulated G1…”
    Get full text
    Journal Article
  4. 4

    Factors impacting adolescent and young adult cancer patients’ decision to pursue genetic counseling and testing by Morand, Megan, Roth, Michael, Peterson, Susan K., Bednar, Erica M., Ramdaney, Aarti, Livingston, J. Andrew, Yarbrough, Angela, Corredor, Jessica

    Published in Supportive care in cancer (01-06-2022)
    “…Purpose Adolescent and young adult (AYA) cancer patients face challenges when navigating cancer treatment and survivorship. Many are at risk for cancer…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy by Wooten, Savannah V., Wang, Fei, Roth, Michael E., Liu, Guanshu, Livingston, J. Andrew, Amini, Behrang, Gilchrist, Susan C., Hildebrandt, Michelle, Kleinerman, Eugenie S.

    Published in Cancer medicine (Malden, MA) (01-11-2023)
    “…Background Early skeletal muscle loss has been observed in adolescent and young adult (AYA) sarcoma patients undergoing treatment. Identification of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor by Dupuis, Megan, Shen, Yulei, Curcio, Christian, Meis, Jeanne M, Wang, Wei-Lien, Amini, Behrang, Rhines, Laurence, Reuther, Jacquelyn, Roy, Angshumoy, Fisher, Kevin E, Conley, Anthony P, Andrew Livingston, J

    Published in Clinical sarcoma research (06-08-2020)
    “…Lipofibromatosis-like neural tumors (LPF-NT) are a newly identified class of rare mesenchymal neoplasms. Current standard of care therapy is surgical resection…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions by Boyce-Fappiano, David, Damron, Ethan P., Farooqi, Ahsan, Mitra, Devarati, Conley, Anthony P., Somaiah, Neeta, Araujo, Dejka M., Livingston, J. Andrew, Ratan, Ravin, Keung, Emily Z., Roland, Christina L., Guadagnolo, B. Ashleigh, Bishop, Andrew J.

    Published in Advances in radiation oncology (01-05-2022)
    “…Given the relative radioresistance of sarcomas and their often large size, conventional palliative radiation therapy (RT) often offers limited tumor control…”
    Get full text
    Journal Article
  16. 16

    Osteosarcoma by Beird, Hannah C., Bielack, Stefan S., Flanagan, Adrienne M., Gill, Jonathan, Heymann, Dominique, Janeway, Katherine A., Livingston, J. Andrew, Roberts, Ryan D., Strauss, Sandra J., Gorlick, Richard

    Published in Nature reviews. Disease primers (08-12-2022)
    “…Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimodal, peaking at 18 and 60 years of age, and is slightly…”
    Get full text
    Journal Article
  17. 17

    Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion by Roth, Michael, Andersen, Clark R, Berkman, Amy, Siegel, Stuart, Cuglievan, Branko, Livingston, J Andrew, Hildebrandt, Michelle, Estrada, Jaime, Bleyer, Archie

    Published in Cancer (07-10-2024)
    “…The Patient Protection and Affordable Care Act (ACA) allowed Americans aged 19-25 years to remain on their parents' health insurance plans until age 26 years…”
    Get full text
    Journal Article
  18. 18

    Genomics and the Immune Landscape of Osteosarcoma by Wu, Chia-Chin, Livingston, J Andrew

    “…Conventional osteosarcoma (OS) is a high-grade intraosseous malignancy with production of osteoid matrix; however, a deeper dive into the underlying genetics…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Improved Survival of Young Adults with Cancer Following the Passage of the Affordable Care Act by Roth, Michael, Berkman, Amy, Andersen, Clark R, Cuglievan, Branko, Andrew Livingston, J, Hildebrandt, Michelle, Bleyer, Archie

    Published in The oncologist (Dayton, Ohio) (04-03-2022)
    “…Compared with their ensured counterparts, uninsured adolescents and young adults (AYAs) with cancer are more likely to present with advanced disease and have…”
    Get full text
    Journal Article